Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic...
26 KB (2,420 words) - 06:06, 17 August 2024
drug cetuximab. They discovered that these individuals had IgE antibodies in their blood that were specifically targeted to the portion of cetuximab which...
36 KB (4,036 words) - 10:21, 9 September 2024
infiltrative disorders such as sarcoidosis. Cetuximab is the first-line therapy for Ménétrier disease. Cetuximab is a monoclonal antibody against epidermal...
10 KB (1,084 words) - 22:07, 15 September 2024
Allergic Facial nerve palsy Anti-cancer treatments such as erlotinib, cetuximab, and panitumumab, which block the function of EGFR (the epidermal growth...
3 KB (220 words) - 20:32, 27 August 2024
Panitumumab (section Panitumumab vs. cetuximab)
the labels of two anti-EGFR monoclonal antibody drugs (panitumumab and cetuximab) indicated for the treatment of metastatic colorectal cancer to include...
16 KB (1,421 words) - 15:40, 14 July 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
92 KB (8,671 words) - 18:15, 17 August 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
121 KB (13,799 words) - 18:31, 13 September 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
31 KB (3,430 words) - 05:24, 28 August 2024
the United States in December 2022 for lung cancer and together with Cetuximab in 2024 for colorectal cancer. Adagrasib is indicated for the treatment...
12 KB (751 words) - 20:10, 9 September 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
149 KB (15,717 words) - 14:45, 15 September 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
68 KB (5,999 words) - 20:41, 31 August 2024
At ImClone, Waksal led the company to develop the cancer drug Erbitux (cetuximab). During the course of its review process with the Food and Drug Administration...
17 KB (1,400 words) - 22:21, 10 September 2024
currently used conventional antibodies like trastuzumab (targeting HER2/neu), cetuximab and panitumumab (both targeting the EGF receptor), using the BiTE approach...
9 KB (1,472 words) - 21:30, 9 September 2024
of a drug depends on the genotype of a patient. For example, Erbitux (cetuximab) increases the survival rate of colorectal cancer patients if they carry...
33 KB (3,391 words) - 18:28, 6 September 2024
disorders, such as Anorexia nervosa Pregnancy Prostaglandin analogues Cetuximab Bimatoprost, Latanoprost Phenytoin Minoxidil Ciclosporin Topiramate Streptomycin...
4 KB (421 words) - 18:23, 28 March 2024
MAbs approved by the FDA for cancer include: Alemtuzumab Bevacizumab Cetuximab Dostarlimab Gemtuzumab ozogamicin Ipilimumab Nivolumab Ofatumumab Panitumumab...
49 KB (4,964 words) - 04:02, 9 August 2024
Examples of radiosensitizing drugs include cisplatin, nimorazole, and cetuximab. The impact of radiotherapy varies between different types of cancer and...
113 KB (13,530 words) - 09:58, 25 August 2024
receptor inhibitors, of which the three FDA approved ones are aflibercept, cetuximab and panitumumab. The primary difference in the approach to low stage rectal...
145 KB (15,781 words) - 22:45, 30 August 2024
FOLFIRI is often[citation needed] combined with bevacizumab, aflibercept, cetuximab or panitumumab to improve efficacy and response rate. In the short term...
4 KB (411 words) - 21:05, 6 May 2024
was predictive of a very poor response to panitumumab (Vectibix) and cetuximab (Erbitux) therapy in colorectal cancer. As of 2008, the most reliable...
45 KB (5,079 words) - 06:39, 25 June 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
17 KB (1,489 words) - 05:47, 7 April 2024
targeted therapies used in head and neck cancers include cetuximab, bevacizumab, and erlotinib. Cetuximab is used for treating people with advanced-stage cancer...
105 KB (11,696 words) - 03:29, 11 August 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
23 KB (1,801 words) - 21:23, 31 August 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
24 KB (1,710 words) - 19:18, 30 August 2024
spondyloarthritis, psoriasis arthritis Cetrelimab mab human PD-1 cancer Cetuximab Erbitux mab chimeric Epidermal growth factor receptor (EGFR) Y metastatic...
136 KB (4,020 words) - 07:14, 15 August 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
13 KB (1,177 words) - 02:19, 4 September 2024
for human therapy include abciximab (ReoPro), basiliximab (Simulect), cetuximab (Erbitux), infliximab (Remicade) and rituximab (MabThera). There are also...
14 KB (1,787 words) - 23:05, 9 January 2024
Monoclonal antibodies such as Infliximab, Adalimumab, Etanercept, Efalizumab, Cetuximab, and OKT3 antibodies. Chemotherapeutic drugs such as Pemetrexed and Cytarabine...
7 KB (776 words) - 15:57, 22 August 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
11 KB (934 words) - 23:22, 24 August 2024
meaning tests being bundled with drugs. Examples include KRAS test with cetuximab and EGFR test with gefitinib. Beside efficacy, germline pharmacogenetics...
63 KB (6,671 words) - 01:29, 1 June 2024